RVTY Revvity, Inc.
XNYS 160.39 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
RVTY
$160.39
—
Key stats
$160.39
- 52-Week Range
- $81.22 – $166.25
- YTD
- +63.41%
- IV Rank (30D)
- 99.2
- Straddle Price
- $19.15
- P/C Vol Ratio
- 0.13
- Market Cap
- $17.7B
- Open
- $159.37
- Day Range
- $159.10 – $161.67
- Volume
- 1,089,209
- Prev Close
- $158.77
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.13% |
| Beta vs SPY | 0.89 |
| Cost of Equity (CAPM) | 9.56% (VRP-adj) |
| WACC | 9.14% |
| Volatility Risk Premium | +14.2pp (IV − HV30) |
| Effective Tax Rate | 9.0% |
| Rev. Growth (YoY, DCF input) | +4.4% |
| DCF Horizon | 12 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.04 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.6B |
| Return on Equity (TTM) | 3.3% |
| Book / Price | 40.3% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 55.0% |
| FCF Margin (TTM) | 19.2% |
| Debt / Equity | 0.36 |
| Quality Score | 4/6 — high quality (12y DCF) |
| Market-Implied Growth | +15.3% (reverse-DCF on current price) |
| SMA 50 | $140.08 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $153.89 |
| Bollinger Width / SMA20 | 4.2% (drives anchor stability) |
| Net Debt | $1.6B |
| Market Cap | $18B |
Peers used for multiples: DHR, PFE, TMO
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
3%
20-Day Fair Value
≈ by Nov 24, 2026
$161.84
α +0.9%
rank 15%
conviction
54%
40-Day Fair Value
≈ by Dec 23, 2026
$162.02
α +1.0%
rank 15%
conviction
34%
60-Day Fair Value
≈ by Jan 21, 2027
$160.26
α -0.1%
rank 15%
conviction
3%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $71.80 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $81.75 | 5% | median 37.3× · 3 peers |
| Peer EV/EBITDA | $151.20 | 6% | median 23.2× · 3 peers |
| Peer P/B | $192.51 | 8% | median 3.0× · 3 peers |
| Peer P/S | $145.23 | 8% | median 5.4× · 3 peers |
| Market Anchor (SMA50) | $140.08 | 39% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $159.71 | 16% | 17 strikes · skew +0.28 |
As of 2026-10-26 · updated
Related
About
- Industry (SIC)
- LABORATORY ANALYTICAL INSTRUMENTS (3826) · industry map
- Exchange
- XNYS
- Market Cap
- $17.7B
- Employees
- 11,000
- List Date
- 1972-06-01
- CIK
- 0000031791
- Next Earnings
- 2026-11-03 (Pre-Market)
- EPS Forecast
- $1.29 (6 est.)
- Headquarters
- Waltham, MA
- Homepage
- https://www.revvity.com
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | -- | -2.94% | 12.62% | 10.85% | 6.84% |
| Feb | -- | 0.30% | -9.33% | -8.20% | -5.74% |
| Mar | -- | -1.98% | -4.16% | -8.35% | -4.83% |
| Apr | -- | -0.77% | -10.43% | -1.48% | -4.23% |
| May | 0.97% | 6.49% | -2.67% | 20.62% | 6.35% |
| Jun | 2.70% | -3.62% | 8.28% | 10.68% | 4.51% |
| Jul | 4.43% | 21.95% | -11.24% | -0.20% | 3.73% |
| Aug | -4.57% | -1.99% | 2.13% | 11.67% | 1.81% |
| Sep | -5.32% | 6.69% | -0.25% | 20.78% | 5.48% |
| Oct | -23.15% | -4.70% | 1.99% | 7.60%* | -4.56% |
| Nov | 7.71% | -4.05% | 12.31% | -- | 5.32% |
| Dec | 19.75% | -4.36% | -5.55% | -- | 3.28% |
| Total | -3.01% | 8.38% | -9.63% | 77.66% | 18.35% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $154.35
SMA 50: $140.95
SMA 200: $110.78
Current: $160.39
EMA 12: $155.65
EMA 26: $150.98
MACD: 4.6772 | Signal: -0.3281
BULLISH
ADX (14): 39.57
TREND
+DI: 27.39
−DI: 12.04
Momentum Oscillators
RSI (14): 67.59
NEUTRAL
Stoch %K: 69.24
Stoch %D: 58.61
Williams %R: -8.55
Volume & Volatility
BB Upper: $159.85
BB Lower: $148.86
OVERBOUGHT
OBV: 26,110,065
Vol SMA 20: 1,790,186
Vol ROC: -2.40%
ATR: $5.66
True Range: $2.90
HV 20: 27.3%
HV 30: 38.8%
HV 60: 36.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical signals indicate a neutral trend, with no clear support or resistance levels.
- Recent news sentiment is neutral, with no significant catalysts driving the stock price.
Primary Risks:
- High volatility, with beta at 1.24, indicating high risk relative to the market.
- Lack of clear technical signals or strong news catalysts to drive price movements.
Investment Thesis:
Revvity (RVTY) is a moderately volatile stock with no clear trend direction. The recent neutral news sentiment and lack of significant catalysts suggest that investors should approach this stock with caution, considering both bullish and bearish scenarios.
Recent News Sentiment Impact:
The recent news headlines have had a neutral impact on the stock price, with no strong buying or selling pressure evident.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Neutral
- Medium-term (1-3 months): Uptrend
- Long-term (3-12 months): Downtrend
Support/Resistance Levels:
- SMA 20: $97.55 (support)
- SMA 50: $102.75 (resistance)
- SMA 200: $95.68 (support)
Momentum Signals:
- RSI interpretation: Neutral (36.49), not indicating overbought or oversold conditions.
- MACD signal: Bearish (-2.87 / Signal: -0.53 / Histogram: -2.35).
- Bollinger Bands position: Squeeze, with price touching the middle band.
Volume Analysis:
- Volume SMA 20: 1126747.26 (moderate volume)
- On-Balance Volume (OBV): -11417580.60 (bearish signal)
- Volume Rate of Change: 72.17% (increasing volume)
News & Sentiment Analysis
Recent Headlines Summary:
The recent news headlines are neutral, with no significant catalysts driving the stock price.
Sentiment Assessment: NEUTRAL
Catalyst Identification: None evident from recent news headlines.
Market Narrative: The market narrative is neutral, with no strong buying or selling pressure evident.
Risk & Volatility Assessment
Beta Interpretation: High risk (1.24) relative to the market.
Volatility Regime: High volatility (0.40), indicating increased price movement.
Options Market Signals:
- IV Rank: 36.0% (Medium)
- Current IV: 55.4%
- Expected Move: $10.90 (39 DTE)
Downside Protection: Support levels at SMA 20 and SMA 200, with a stop-loss level at $85.00.
Market Context & Positioning
Sector Performance: Revvity is underperforming its sector average.
Institutional Activity: Moderate institutional interest, but no clear buying or selling pressure.
Correlation Analysis: The stock has a moderate correlation (0.59) with the broader market.
Relative Valuation: Position within a trading range, with no clear overbought or oversold conditions.
Key Levels & Action Items
Critical Price Levels:
- Support at SMA 20 ($97.55)
- Resistance at SMA 50 ($102.75)
Breakout/Breakdown Levels:
- Breakout above $105.00 for bullish momentum
- Breakdown below $90.76 for bearish momentum
Time-Sensitive Catalysts: None evident from recent news headlines.
Risk Management: Consider a stop-loss level at $85.00 and position sizing considering the high volatility.
Note: This analysis is based on the provided data, and any changes to the data or market conditions may affect the conclusions drawn.
Generated
News
All RVTY news →
Earnings History
10 of 13 under expected move
Avg Expected Move
9.07%
Avg Actual Move
4.39%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2023-08-01 | Pre-Market | 6.86% | 0.26% | 0.04x | Within |
| 2023-10-30 | Pre-Market | 7.61% | 16.13% | 2.12x | Exceeded |
| 2024-01-09 | Pre-Market | 5.35% | 2.06% | 0.39x | Within |
| 2024-04-29 | Pre-Market | 8.28% | 3.46% | 0.42x | Within |
| 2024-07-29 | Pre-Market | 9.03% | 9.07% | 1.00x | Exceeded |
| 2024-11-04 | Pre-Market | 9.01% | 3.12% | 0.35x | Within |
| 2025-01-31 | Pre-Market | 8.48% | 0.56% | 0.07x | Within |
| 2025-04-28 | Pre-Market | 10.23% | 0.82% | 0.08x | Within |
| 2025-07-28 | Pre-Market | 7.91% | 8.32% | 1.05x | Exceeded |
| 2025-10-27 | Pre-Market | 14.16% | 1.75% | 0.12x | Within |
| 2026-02-02 | Pre-Market | 10.89% | 1.57% | 0.14x | Within |
| 2026-05-05 | Pre-Market | 10.32% | 6.69% | 0.65x | Within |
| 2026-08-04 | Pre-Market | 9.72% | 3.32% | 0.34x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
RVTY Options Activity & IV Rank
RVTY IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 54.7%
7-DTE IV: —
Expected Move: $19.15
7-DTE Move: $19.15
Days to Exp: 25 (2026-11-20)
Options Flow
Call Volume: 528
Put Volume: 68
P/C Volume: 0.129
BULLISH
Call OI: 2,785
Put OI: 1,489
P/C OI: 0.535
Total OI: 4,274
ATM Options Pricing
ATM Call: $9.95
ATM Put: $9.20
Call %: 6.2%
Put %: 5.7%
Chain Summary
Chain Volume: 1,830
Chain OI: 7,474
Last Updated: 10/26/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 92nd percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
92%
vs own history
GEX tilt
+0.88
OI-weighted, today
Vanna tilt
+0.86
δ-sensitivity to IV
Charm tilt
-0.91
δ-decay vs time
Vanna tilt +0.86: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.91: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 17 ATM contracts, 4k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · No data
30 DTE / 10d
100%
+21.2
pts
EXTREME
as of Oct 26 · ATM 57.4% / Wing 78.6%
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)99.2HighOct 26
Straddle Price (30 DTE)$19.15Oct 26
Beta Analysis
Risk Metrics
Beta: 1.1341
Alpha: 41.20%
Correlation: 0.3725
R-Squared: 13.9%
Stock Volatility: 38.8%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Above average volatility - stock moves with market amplification
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
RVTY Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 113,028,500 (as of 2026-07-05)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
8 filers$12.38M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Caption Management, LLC | $2.78M | 22.46% | 2026-06-30 |
| 2 | PEAK6 LLC | $2.54M | 20.49% | 2026-06-30 |
| 3 | Simplex Trading, LLC Custodian | $2.39M | 19.32% | 2026-06-30 |
| 4 | Susquehanna International Group, LLP Custodian | $1.58M | 12.76% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $1.26M | 10.15% | 2026-06-30 |
| 6 | Citadel Advisors LLC Custodian | $823.32K | 6.65% | 2026-06-30 |
| 7 | Jane Street Group, LLC Custodian | $812.20K | 6.56% | 2026-06-30 |
| 8 | Walleye Capital LLC | $200.27K | 1.62% | 2026-06-30 |
7 filers$5.41M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $2.60M | 48.12% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $1.37M | 25.30% | 2026-06-30 |
| 3 | IMC-Chicago, LLC Custodian | $778.82K | 14.40% | 2026-06-30 |
| 4 | Wolverine Trading, LLC Custodian | $303.12K | 5.60% | 2025-09-30 |
| 5 | Jane Street Group, LLC Custodian | $211.39K | 3.91% | 2026-06-30 |
| 6 | Walleye Capital LLC | $100.13K | 1.85% | 2026-06-30 |
| 7 | Simplex Trading, LLC Custodian | $44.50K | 0.82% | 2026-06-30 |
RVTY Insider Trading (Form 4)
Latest: 2026-10-02Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Anita Gonzales | VP and CAO | Sell (S) | −84 | $155.48 | -$13.1K | EDGAR |
| 2026-09-23 | Maxwell Krakowiak | Please See Remarks | Sell (S) | −1,631 | $144.53 | -$235.7K | EDGAR |
| 2026-09-18 | Tajinder S Vohra | Please See Remarks | Sell (S) | −7,330 | $140.88 | -$1.03M | EDGAR |
| 2026-08-25 | Alexis P Michas | Director | Gift (G) | −285 | — | EDGAR | |
| 2026-08-18 | Joel S Goldberg | Please See Remarks | Gift (G) | — | — | EDGAR | |
| 2026-08-17 | Prahlad R. Singh | Please See Remarks | Gift (G) | — | — | EDGAR | |
| 2026-07-22 | Anita Gonzales | Vice President and CAO | Sell (S) | −85 | $109.48 | -$9.3K | EDGAR |
| 2026-06-17 | Anita Gonzales | Vice President and CAO | Tax (F) | −33 | $99.66 | -$3.3K | EDGAR |
| 2026-05-11 | Peter Barrett | Director | Award (A) | +2,280 | — | EDGAR | |
| 2026-05-11 | Pascale Witz | Director | Award (A) | +2,280 | — | EDGAR | |
| 2026-05-11 | Michelle McMurry-Heath | Director | Award (A) | +2,280 | — | EDGAR | |
| 2026-05-11 | Michel Vounatsos | Director | Award (A) | +2,280 | — | EDGAR | |
| 2026-05-11 | Samuel R. Chapin | Director | Award (A) | +2,280 | — | EDGAR | |
| 2026-05-11 | Frank Witney | Director | Award (A) | +2,280 | — | EDGAR | |
| 2026-05-11 | Michael A Klobuchar | Director | Award (A) | +2,280 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
RVTY Insider Holdings
15 insiders · @ $160.39
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Prahlad R. Singh | Please See Remarks | 159,895 | $25.65M | -$7.02M | 9 | 2026-08-17 |
| 2 | Joel S Goldberg | Please See Remarks | 105,223 | $16.88M | -$5.75M | 9 | 2026-08-18 |
| 3 | Alexis P Michas | Director | 70,765 | $11.35M | -$695.2K | 9 | 2026-08-25 |
| 4 | Peter Barrett | Director | 28,293 | $4.54M | $0 | 4 | 2026-05-11 |
| 5 | Frank Witney | Director | 23,354 | $3.75M | $0 | 4 | 2026-05-11 |
| 6 | Samuel R. Chapin | Director | 22,676 | $3.64M | $0 | 4 | 2026-05-11 |
| 7 | Tajinder S Vohra | Please See Remarks | 18,818 | $3.02M | -$3.90M | 11 | 2026-09-18 |
| 8 | Miriame Victor | Please See Remarks | 18,122 | $2.91M | -$180.9K | 6 | 2026-02-26 |
| 9 | Pascale Witz | Director | 15,985 | $2.56M | $0 | 4 | 2026-05-11 |
| 10 | Maxwell Krakowiak | Please See Remarks | 14,781 | $2.37M | -$235.7K | 9 | 2026-09-23 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
RVTY Board & Officers
As of SEC filings through Oct 2, 2026Directors 10
- Alexis P Michas · on file since May 2006
- Peter Barrett · since Feb 7, 2012
- Frank Witney · since Jul 27, 2016
- Samuel R. Chapin · since Oct 15, 2016
- Pascale Witz · since Oct 27, 2017
- Prahlad R. Singh · listed since Jan 2020
- Michel Vounatsos · since Mar 1, 2020
- Michelle McMurry-Heath · since Jul 22, 2022
- Michael A Klobuchar · since Feb 1, 2024
- Sophie V. Vandebroek · since Feb 1, 2024
Officers 6
- Prahlad R. Singh · President, Chief Executive Officer and Director · listed since Jan 2020
- Joel S Goldberg · Senior Vice President, Administration, General Counsel and Secretary · listed since Mar 2015
- Tajinder S Vohra · Senior Vice President, Global Operations · since Jan 29, 2018
- Miriame Victor · Senior Vice President, Chief Commercial Officer · since Jan 4, 2021
- Maxwell Krakowiak · Senior Vice President and Chief Financial Officer · since Sep 6, 2022
- Anita Gonzales · Vice President and Chief Accounting Officer · listed since Dec 2025
Changes in the last 10 years (19)
| Dec 17, 2025 | Anita Gonzales listed as Vice President and Chief Accounting Officer (previously Vice President and Controller) in SEC filings |
| Feb 1, 2024 | Sophie V. Vandebroek became a director |
| Feb 1, 2024 | Michael A Klobuchar became a director |
| Jan 25, 2024 | The company announced the departure of Sylvie Gregoire from the board in an SEC filing |
| May 13, 2023 | Anita Gonzales became Vice President and Controller |
| Sep 6, 2022 | Maxwell Krakowiak became Senior Vice President and Chief Financial Officer |
| Aug 15, 2022 | The company announced the departure of James M Mock as Senior Vice President and Chief Financial Officer in an SEC filing |
| Jul 22, 2022 | Michelle McMurry-Heath became a director |
| Feb 8, 2021 | Andrew Okun listed as Vice President, Chief Accounting Officer and Treasurer (previously Vice President and Chief Accounting Officer) in SEC filings |
| Jan 4, 2021 | Miriame Victor became Senior Vice President, Chief Commercial Officer |
| Mar 1, 2020 | Michel Vounatsos became a director |
| Jan 31, 2020 | Prahlad R. Singh listed as President, Chief Executive Officer and Director (previously President and COO) in SEC filings |
| Jan 31, 2020 | Prahlad R. Singh first listed as a director in an SEC filing |
| May 2, 2019 | James Corbett reported in an SEC filing no longer being Executive Vice President and President, Discovery & Analytical Solutions |
| Feb 7, 2019 | Robert F Friel listed as Chairman and CEO (previously President and CEO) in SEC filings |
| Feb 7, 2019 | Prahlad R. Singh listed as President and COO (previously Senior Vice President and President, Diagnostics) in SEC filings |
| May 1, 2018 | James M Mock became Senior Vice President and Chief Financial Officer |
| Jan 29, 2018 | Tajinder S Vohra became Senior Vice President, Global Operations |
| Oct 27, 2017 | Pascale Witz became a director |
Not reported recently (8)
- Daniel R Tereau · Last reported as Senior Vice President, Strategy and Business Development in an SEC filing dated Feb 7, 2024
- Andrew Okun · Last reported as Vice President, Chief Accounting Officer and Treasurer in an SEC filing dated Apr 14, 2023
- Deborah A. Butters · Last reported as Senior Vice President, Chief Human Resources Officer in an SEC filing dated Feb 10, 2020
- Patrick J Sullivan · Last reported as a director in an SEC filing dated May 1, 2019
- Robert F Friel · Last reported as a director in an SEC filing dated Feb 14, 2019
- Nicholas A Lopardo · Last reported as a director in an SEC filing dated Feb 7, 2019
- Frank Anders Wilson · Last reported as Senior Vice President and Chief Financial Officer in an SEC filing dated Mar 6, 2018
- Vicki L Sato · Last reported as a director in an SEC filing dated Feb 10, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
RVTY Proposed Insider Sales (Form 144)
Latest: 2026-10-01
? Form 144 Guide
Last 30d:
1 filing
· $13K notice value
· Last 90d:
3 filings
· $1.3M notice value
· 3 unique filers
· 100% under 10b5-1 plans
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Vohra Tajinder S (1, $1.0M) · Krakowiak Maxwell (1, $236K) · Gonzales Anita (1, $13K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-01 | Gonzales Anita | Officer | 84 | $13.1K | 2026-10-01 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-09-21 | Krakowiak Maxwell | Officer | 1,631 | $235.7K | 2026-09-21 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-09-16 | Vohra Tajinder S | Officer | 7,330 | $1.03M | 2026-09-16 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-20 | Gonzales Anita | Officer | 85 | $9.3K | 2026-07-20 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-04-20 | Gonzales Anita | Officer | 80 | $7.4K | 2026-04-20 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-02-24 | Victor Miriame | Officer | 1,862 | $180.9K | 2026-02-24 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-02-23 | McMurry-Heath Michelle | Director | 600 | $58.4K | 2026-02-23 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-05 | Singh Prahlad R. | Officer, Director | 25,525 | $2.56M | 2026-02-05 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-02-05 | Goldberg Joel S | Officer | 12,717 | $1.27M | 2026-02-05 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-02-02 | Vohra Tajinder S | Officer | 5,756 | $601.5K | 2026-02-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-12
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-05 | 0000031791-26-000016 | EDGAR |
| 2026-05-01 | 0001193125-26-201401 | EDGAR |
| 2026-02-02 | 0000031791-26-000007 | EDGAR |
| 2026-01-13 | 0000031791-26-000003 | EDGAR |
| 2025-10-27 | 0000031791-25-000032 | EDGAR |
| 2025-10-24 | 0001193125-25-249958 | EDGAR |
| 2025-07-28 | 0000031791-25-000022 | EDGAR |
| 2025-04-28 | 0000031791-25-000012 | EDGAR |
| 2025-04-25 | 0001193125-25-096747 | EDGAR |
| 2025-01-31 | 0000031791-25-000006 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-24 | 0000031791-26-000012 | EDGAR |
| 2025-02-25 | 0000031791-25-000009 | EDGAR |
| 2024-02-27 | 0000031791-24-000004 | EDGAR |
| 2023-03-01 | 0000031791-23-000004 | EDGAR |
| 2022-03-03 | 0000031791-22-000003 | EDGAR |
| 2021-03-02 | 0000031791-21-000003 | EDGAR |
| 2020-02-25 | 0000031791-20-000003 | EDGAR |
| 2019-02-26 | 0000031791-19-000003 | EDGAR |
| 2018-02-27 | 0000031791-18-000004 | EDGAR |
| 2017-02-28 | 0000031791-17-000003 | EDGAR |
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-12 | 0000031791-26-000019 | EDGAR |
| 2025-11-04 | 0000031791-25-000037 | EDGAR |
| 2025-08-05 | 0000031791-25-000026 | EDGAR |
| 2025-05-06 | 0000031791-25-000015 | EDGAR |
| 2024-11-06 | 0000031791-24-000028 | EDGAR |
| 2024-08-06 | 0000031791-24-000021 | EDGAR |
| 2024-05-07 | 0000031791-24-000014 | EDGAR |
| 2023-11-07 | 0000031791-23-000014 | EDGAR |
| 2023-08-09 | 0000031791-23-000011 | EDGAR |
| 2023-05-12 | 0000031791-23-000008 | EDGAR |
ETF Holders
180 ETFs hold RVTY
25 shown · $3.28B total exposure · 0.04% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.02% | $543.5M | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.03% | $447.9M | — | 2026-09-30 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.22% | $384.0M | — | 2026-09-30 |
| 4 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.25% | $251.7M | — | 2026-10-24 |
| 5 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.39% | $249.9M | — | 2026-09-30 |
| 6 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.03% | $235.7M | $880.6B | 2026-10-23 |
| 7 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.03% | $218.3M | $807.9B | 2026-10-23 |
| 8 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.50% | $153.9M | — | 2026-10-23 |
| 9 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.27% | $127.9M | $47.0B | 2026-10-23 |
| 10 | TCAF T. Rowe Price Capital Appreciation Equity ETF | Nport | 1.29% | $95.1M | — | 2026-06-30 |
| 11 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.13% | $74.3M | $57.3B | 2026-10-23 |
| 12 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.23% | $64.2M | — | 2026-10-23 |
| 13 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.07% | $60.9M | — | 2026-10-23 |
| 14 | VHT Vanguard Health Care ETF | Vanguard | 0.24% | $52.1M | — | 2026-09-30 |
| 15 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.15% | $50.8M | — | 2026-10-23 |
| 16 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.03% | $49.0M | $181.7B | 2026-10-23 |
| 17 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.05% | $39.6M | $84.8B | 2026-10-23 |
| 18 | SCHM Schwab U.S. Mid-Cap ETF | Nport | 0.22% | $32.0M | — | 2026-05-31 |
| 19 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.06% | $29.3M | $50.6B | 2026-10-23 |
| 20 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.17% | $27.0M | $15.7B | 2026-10-23 |
| 21 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.02% | $23.5M | $96.5B | 2026-10-23 |
| 22 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 0.06% | $22.6M | $38.6B | 2026-10-23 |
| 23 | RSPH Invesco S&P 500 Equal Weight Health Care ETF | Invesco | 1.97% | $19.0M | — | 2026-10-24 |
| 24 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.04% | $16.4M | — | 2026-10-23 |
| 25 | IUSV iShares Core S&P U.S. Value ETF | iShares (BlackRock) | 0.06% | $15.7M | $28.4B | 2026-10-23 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
76.38
TTM Diluted EPS
$2.10
TTM Revenue
$2.91B
TTM Net Income
$237.55M
TTM Op. Cash Flow
$627.63M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-07-05 | $729.69M | $51.82M | $0.47 | $191.94M |
| Q1 '26 | 2026-04-05 | $711.12M | $40.72M | $0.36 | $115.23M |
| Q4 '25 | 2025-12-28 | $772.06M | $98.36M | $0.86 | $181.96M |
| Q3 '25 | 2025-09-28 | $698.95M | $46.65M | $0.40 | $138.50M |
| Q2 '25 | 2025-06-29 | $720.28M | $53.95M | $0.46 | $134.32M |
| Q1 '25 | 2025-03-30 | $664.76M | $42.24M | $0.35 | $128.16M |
| Q4 '24 | 2024-12-29 | $729.37M | $94.64M | $0.78 | $174.23M |
| Q3 '24 | 2024-09-29 | $684.05M | $94.37M | $0.77 | $147.88M |
| Q2 '24 | 2024-06-30 | $691.68M | $55.36M | $0.45 | $158.62M |
| Q1 '24 | 2024-03-31 | $649.92M | $26.01M | $0.21 | $147.56M |
| Q4 '23 | 2023-12-31 | $695.90M | $78.56M | $0.65 | $196.61M |
| Q3 '23 | 2023-10-01 | $670.74M | $9.50M | $0.08 | $-33.48M |
Q2 2026 • period ending 2026-07-05 • filed 2026-08-11
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
76.38
P/B
2.51
P/S
6.23
EV/EBITDA
25.60
EV/Sales
6.78
ROE
3.3%
ROA
2.0%
Div Yield
0.18%
FCF Yield
3.46%
Debt/Equity
0.36
Current Ratio
—
Market Cap
$18.13B
as of 2026-10-26
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
6.30M
SI % of Float
5.67%
Days to Cover
2.42
Short Vol Ratio
52.0%
Free Float
111.11M
Float %
99.6%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-09-08